Advanced Search


Study ID Status Title Patient Level Data
112844 Completed A Phase IIa, Randomized, Single-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of 28-day Repeat Oral Doses of GSK1278863A in anemic pre-dialysis and hemodialysis-dependent patients
112851 Completed A randomised, double-blind, placebo-controlled, 2-way crossover study to determine the efficacy of repeat inhaled doses of GW870086X on FEV1 in mild to moderate asthmatics Study Listed on
112855 Completed An Open-Label, Single-Arm, Phase I Study to Evaluate the Effect of Ofatumumab on Cardiac Repolarization (QTc Duration) in Patients with Fludarabine-Refractory B-cell Chronic Lymphocytic Leukemia
112861 Completed A single-blind, randomised, placebo-controlled, parallel group study to investigate safety, tolerability, pharmacokinetics and the effects on cardiac function of repeat oral doses of SB-649868 in adult and elderly healthy volunteers Study Listed on
112864 Completed A randomised, double-blind, placebo-controlled 4-period cross-over study to assess the efficacy and safety of repeat dose intranasal GSK1004723 (1000µg), oral GSK835726 (10mg) and cetirizine (10mg) in the environmental challenge chamber in subjects with seasonal allergic rhinitis Study Listed on
112865 Withdrawn Immunogenicity and safety of GSK Biologicals’ (pre-) pandemic influenza candidate vaccine GSK 1562902A.
112867 Completed An open-label positron emission tomography study to investigate and quantify brain and tumour penetration of [11C]lapatinib in subjects with HER2-overexpressing breast cancer
112868 Terminated An observational case control study of effectiveness of influenza vaccination and burden of illness in community-dwelling elderly with influenza-like illness in southern Brazil
112872 Completed HIV treatment and CVD events - Ingenix. Retrospective Database Analysis of Patients with Human Immunodeficiency Virus (HIV) Treatment and Cardiovascular Disease (CVD) Events
112880 Completed An observational multi-cohort study on the use of Fosamprenavir-Ritonavir among HIV-infected children and adolescents in Europe
112883 Completed Cohort study to document background rates of hypertension and Liver Function Test (LFT) elevations in users of Tyrosine Kinase inhibiting drugs-Varian Oncology Database
112885 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of birth defects associated with exposure to GSK HIV drugs during pregnancy
112891 Completed An open label, randomised, three-way cross-over study to evaluate the pharmacokinetics, effect of food, safety and tolerability of a new tablet formulation of GSK1144814 in healthy male and female subjects
112896 Completed Post marketing surveillance to monitor the reactogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus vaccine, Rotarix™ when administered according to the Prescribing Information to Indian infants
112898 Completed Safety and immunogenicity study of GSK Biologicals’ candidate tuberculosis vaccine (692342) when administered to healthy HIV-negative adolescents living in a TB endemic region Study Listed on
112899 Completed Safety and immunogenicity study of GSK Biologicals’ candidate tuberculosis vaccine (692342) when administered to healthy infants Study Listed on
112909 Completed Booster vaccination with pneumococcal vaccine GSK1024850A in primed children and catch-up vaccination in unprimed children Study Listed on
112913 Completed Lamotrigine Pregnancy Registry (LAM05)
112914 Completed The Sumatriptan and Naratriptan Pregnancy Registry
112921 Completed Impact of immediate or delayed prophylactic antipyretic treatment on the immunogenicity, reactogenicity and safety of GlaxoSmithKline Biologicals’ pneumococcal vaccine 1024850A and the co-administered DTPa-combined vaccines Study Listed on
112924 Completed Drug Use Investigation for AMERGE (naratriptan hydrochloride) Tablet
112925 Completed Special Drug Use Investigation for AMERGE Tablet (Long-term)
112929 Completed A Phase 2a Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK1265744 Monotherapy Versus Placebo in HIV-1 Infected Adults (ITZ112929)
112930 Completed An open-label, randomized, adaptive design, two-period crossover study in cancer patients to evaluate the bioequivalence of alternative formulations of lapatinib compared to the commercial tablet
112931 Completed Immunogenicity, safety and reactogenicity of GSK Biologicals’ Hib-MenCY-TT (MenHibrix®) vaccine 792014 compared to Merck & Co, Inc. Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) vaccine in healthy infants and toddlers



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.